Yi-zi Zheng
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Reply: Chemotherapy for Invasive Papillary Carcinoma: Survival Benefit or Patient Selection?
Journal: The oncologist
Published: May 21, 2026
Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis.
Journal: Breast (Edinburgh, Scotland)
Published: November 10, 2024
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
Journal: Breast cancer (Dove Medical Press)
Published: August 23, 2022
Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study.
Journal: Clinical epidemiology
Published: October 16, 2021
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer.
Journal: Theranostics
Published: February 17, 2020
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.
Journal: Cancer research
Published: November 16, 2017
Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
Journal: Oncotarget
Published: February 26, 2016
The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
Journal: Cancer letters
Published: February 19, 2016
Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study.
Journal: Scientific reports
Published: January 26, 2016
Last Updated: 09/26/2026